New cocktail shows promise for tough lung cancer
Disease control
Completed
This study tested a combination of three drugs—nivolumab, ipilimumab, and plinabulin—in 39 adults with recurrent small cell lung cancer that had worsened after initial chemotherapy. The goal was to find the safest dose and see if the combo could slow cancer growth. Results from t…
Phase: PHASE1, PHASE2 • Sponsor: Salma Sabbour • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC